Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated Mesenchymal Stem Cell Therapy for Xerostomia in Head and Neck Cancer Survivors
NCT07290946Phase 2Not yet recruiting
- Start
- Dec 2025
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of CSCC_ASC in xerostomia, hyposalivation. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
CSCC_ASC
03
Conditions
xerostomiahyposalivation
Beyond the preview
Go deeper on NCT07290946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07290946.